Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol-Directed Active Surveillance for Older Women With Small, Screen-Detected, ER+/HER2- Breast Cancer

NCT07262138 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT07262138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07262138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol-Directed Active Surveillance for Older Women With Small, Screen-Detected, ER+/HER2- Breast Cancer
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2025
Completion date
December 31, 2030
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early stage estrogen receptor (er) positive breast cancer